Key financial indicators
Overview of key financial indicators in 1-12 2020
| Sales (in HRKm) | 2020 | 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,526.5 | 4,460.2 | 1.5% |
| Sales revenues of Podravka Group | 4,503.2 | 4,409.4 | 2.1% |
| Sales revenues of Food | 3,527.0 | 3,454.0 | 2.1% |
| Sales revenues of Pharma | 976.2 | 955.4 | 2.2% |
| Podravka Group's profitability (in HRKm) | 2020 | 2019 | % change |
| Group's gross profit | 1,659.4 | 1,631.5 | 1.7% |
| Group's gross profit margin | 36.8% | 37.0% | -15 bb |
| Group's EBITDA | 546.7 | 509.0 | 7.4% |
| Group's EBITDA margin | 12.1% | 11.5% | +60 bb |
| Group's EBIT | 332.3 | 283.5 | 17.2% |
| Group's EBIT margin | 7.4% | 6.4% | + 95 bb |
| Group's net profit after MI | 248.9 | 221.6 | 12.3% |
| Group's net profit margin after MI | 5.5% | 5.0% | +50 bb |
| Podravka Group's balance sheet (in HRKm) | 31.12.2020 | 31.12.2019 | % change |
| Total assets | 4,940.6 | 4,883.8 | 1.2% |
| Shareholders' equity | 3,372.1 | 3,173.1 | 6.3% |
| Minority interests | 54.9 | 46.3 | 18.5% |
| Cash and cash equivalents | 51.9 | 55.6 | (0.1%) |
| Financial debt | 785.2 | 878.0 | (0.1%) |
| Net debt | 733.3 | 822.4 | (0.1%) |
| Podravka Group's cash flow (in HRKm) | 2020 | 2019 | % change |
| Net cash flow from operating activities | 384.5 | 272.9 | 40.9% |
| Capital expenditures | 192.4 | 153.9 | 110f% |
| Depreciation and amortization | 218.2 | 216.0 | 1.0% |
| Free cash flow | 192.1 | 119.0 | 61.4% |
| Podravka Group's ratios and indicators | 31.12.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,650 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.5 | 14.9 | (0.2%) |
| Sales revenues / Number of employees (in HRK000) | 677.2 | 662.9 | 110.1f% |
| Net profit after MI / Sales revenues (in HRK000) | 37.4 | 33.3 | 12.4% |
| Return on average assets | 5.1% | 4.7% | +41 bb |
| Return on average capital | 7.6% | 7.3% | +26 bb |
| Return on average invested capital | 6.5% | 6.3% | +23 bb |
| Total shareholders' equity / Total assets | 69.4% | 65.9% | +344 bb |
| EBIT / P&L interest expense | 28.3 | 20.1 | 40.5% |
| Net debt / EBITDA | 1.4 | 1.6 | (0.2%) |
| Sales (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,339.5 | 3,261.3 | 2.4% |
| Sales revenues of Podravka Group | 3,328.6 | 3,238.5 | 2.8% |
| Sales revenues of Food | 2,619.7 | 2,550.3 | 2.7% |
| Sales revenues of Pharma | 708.9 | 688.2 | 3.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Group's gross profit | 1,232.5 | 1,206.1 | 2.2% |
| Group's gross profit margin | 37.0% | 37.2% | -21 bb |
| Group's EBITDA | 435.5 | 413.2 | 5.4% |
| Group's EBITDA margin | 13.1% | 12.8% | +33 bb |
| Group's EBIT | 272.7 | 252.2 | 8.1% |
| Group's EBIT margin | 8.2% | 7.8% | +41 bb |
| Group's net profit after MI | 210.1 | 194.3 | 8.1% |
| Group's net profit margin after MI | 6.3% | 6.0% | +31 bb |
| Podravka Group's balance sheet (in HRKm) | 30.9.2020 | 31.12.2019 | % change |
| Total assets | 5,102.8 | 4,883.8 | 4.5% |
| Shareholders' equity | 3,329.6 | 3,173.1 | 4.9% |
| Minority interests | 50.7 | 46.3 | 9.4% |
| Cash and cash equivalents | 131.2 | 55.6 | 136.0% |
| Financial debt | 888.7 | 878.0 | 1.2% |
| Net debt | 757.5 | 822.4 | (0.1%) |
| Podravka Group's cash flow (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Net cash flow from operating activities | 290.5 | 175.7 | 65.3% |
| Capital expenditures | 139.8 | 101.4 | (0.4%) |
| Depreciation and amortization | 162.8 | 161.1 | 1.1% |
| Free cash flow | 150.7 | 74.3 | 102.9% |
| Podravka Group's ratios and indicators | 30.9.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,807 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.8 | 14.9 | (0.2%) |
| Sales revenues / Number of employees (in HRK000) | 661.0 | 662.9 | (0.0%) |
| Net profit after MI / Sales revenues (in HRK000) | 34.9 | 33.3 | 4.7% |
| Return on average assets | 4.9% | 4.7% | +20 bb |
| Return on average capital | 7.4% | 7.3% | +11 bb |
| Return on average invested capital | 6.5% | 6.3% | +29 bb |
| Total shareholders' equity / Total assets | 66.2% | 65.9% | +32 bb |
| EBIT / P&L interest expense | 27.0 | 20.1 | 33.9% |
| Net debt / EBITDA | 1.4 | 1.6 | (0.1%) |
| Sales (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | ='[1]Grupa konsol '!$W$9/1000 | ='[1]Grupa konsol '!$K$9/1000 | =+B2/C2-1 |
| Sales revenues of Podravka Group | ='[1]Grupa konsol '!$W$14/1000 | ='[1]Grupa konsol '!$K$14/1000 | =+B3/C3-1 |
| Sales revenues of Food | ='[2]Profitabilnost 1H 2020.'!$C$25 | ='[2]Profitabilnost 1H 2020.'!$B$25 | =+B4/C4-1 |
| Sales revenues of Pharma | ='[2]Profitabilnost 1H 2020.'!$C$46 | ='[2]Profitabilnost 1H 2020.'!$B$46 | =+B5/C5-1 |
| Podravka Group's profitability (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Group's gross profit | ='[2]Profitabilnost 1H 2020.'!$C$4 | ='[2]Profitabilnost 1H 2020.'!$B$4 | =+B7/C7-1 |
| Group's gross profit margin | ='[2]Profitabilnost 1H 2020.'!$C$9 | ='[2]Profitabilnost 1H 2020.'!$B$9 | =+IF((ROUND((B8-C8)*10000/1,0))>0,"+"&ROUND((B8-C8)*10000/1,0)&" bb",ROUND((B8-C8)*10000/1,0)&" bb") |
| Group's EBITDA | ='[2]Profitabilnost 1H 2020.'!$C$5 | ='[2]Profitabilnost 1H 2020.'!$B$5 | =+B9/C9-1 |
| Group's EBITDA margin | ='[2]Profitabilnost 1H 2020.'!$C$10 | ='[2]Profitabilnost 1H 2020.'!$B$10 | =+IF((ROUND((B10-C10)*10000/1,0))>0,"+"&ROUND((B10-C10)*10000/1,0)&" bb",ROUND((B10-C10)*10000/1,0)&" bb") |
| Group's EBIT | ='[2]Profitabilnost 1H 2020.'!$C$6 | ='[2]Profitabilnost 1H 2020.'!$B$6 | =+B11/C11-1 |
| Group's EBIT margin | ='[2]Profitabilnost 1H 2020.'!$C$11 | ='[2]Profitabilnost 1H 2020.'!$B$11 | =+IF((ROUND((B12-C12)*10000/1,0))>0,"+"&ROUND((B12-C12)*10000/1,0)&" bb",ROUND((B12-C12)*10000/1,0)&" bb") |
| Group's net profit after MI | ='[2]Profitabilnost 1H 2020.'!$C$7 | ='[2]Profitabilnost 1H 2020.'!$B$7 | =+B13/C13-1 |
| Group's net profit margin after MI | ='[2]Profitabilnost 1H 2020.'!$C$12 | ='[2]Profitabilnost 1H 2020.'!$B$12 | =+IF((ROUND((B14-C14)*10000/1,0))>0,"+"&ROUND((B14-C14)*10000/1,0)&" bb",ROUND((B14-C14)*10000/1,0)&" bb") |
| Podravka Group's balance sheet (in HRKm) | 30.6.2020 | 31.12.2019 | % change |
| Total assets | =[2]BS!$E$27/1000 | =[2]BS!$C$27/1000 | =+B16/C16-1 |
| Shareholders' equity | =[2]BS!$E$37/1000 | =[2]BS!$C$37/1000 | =+B17/C17-1 |
| Minority interests | =[2]BS!$E$38/1000 | =[2]BS!$C$38/1000 | =+B18/C18-1 |
| Cash and cash equivalents | =[2]BS!$E$23/1000 | =[2]BS!$C$23/1000 | =+B19/C19-1 |
| Financial debt | =[2]Zaduženost!$C$22 | =[2]Zaduženost!$B$22 | =+B20/C20-1 |
| Net debt | =[2]Zaduženost!$C$21 | =[2]Zaduženost!$B$21 | =+B21/C21-1 |
| Podravka Group's cash flow (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Net cash flow from operating activities | =[2]CF!$D$51/1000 | =[2]CF!$C$51/1000 | =+B23/C23-1 |
| Capital expenditures | =-[2]CF!$D$59/1000 | =-[2]CF!$C$59/1000 | =+B24/C24-1 |
| Depreciation and amortization | =[2]CF!$D$9/1000 | =[2]CF!$C$9/1000 | =+B25/C25-1 |
| Free cash flow | =B23-B24 | =C23-C24 | =+B26/C26-1 |
| Podravka Group's ratios and indicators | 30.6.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,785 | 6,652 | =+B28/C28-1 |
| P&L interest expense (in HRKm) | =[2]Zaduženost!$C$3 | =[2]Zaduženost!$B$3 | =+B29/C29-1 |
| Sales revenues / Number of employees (in HRK000) | =[2]Dionica!$AI$21*1000/B28 | =[2]Dionica!$AI$24*1000/C28 | =+B30/C30-1 |
| Net profit after MI / Sales revenues (in HRK000) | =[2]Dionica!$AI$36*1000/B28 | =[2]Dionica!$AI$39*1000/C28 | =+B31/C31-1 |
| Return on average assets | ='[2]Ključni pokazatelji u razdoblju'!$C$16 | ='[2]Ključni pokazatelji u razdoblju'!$B$16 | =+IF((ROUND((B32-C32)*10000/1,0))>0,"+"&ROUND((B32-C32)*10000/1,0)&" bb",ROUND((B32-C32)*10000/1,0)&" bb") |
| Return on average capital | ='[2]Ključni pokazatelji u razdoblju'!$C$15 | ='[2]Ključni pokazatelji u razdoblju'!$B$15 | =+IF((ROUND((B33-C33)*10000/1,0))>0,"+"&ROUND((B33-C33)*10000/1,0)&" bb",ROUND((B33-C33)*10000/1,0)&" bb") |
| Return on average invested capital | ='[2]Ključni pokazatelji u razdoblju'!$H$25 | ='[2]Ključni pokazatelji u razdoblju'!$I$25 | =+IF((ROUND((B34-C34)*10000/1,0))>0,"+"&ROUND((B34-C34)*10000/1,0)&" bb",ROUND((B34-C34)*10000/1,0)&" bb") |
| Total shareholders' equity / Total assets | =(B17+B18)/B16 | =(C17+C18)/C16 | =+IF((ROUND((B35-C35)*10000/1,0))>0,"+"&ROUND((B35-C35)*10000/1,0)&" bb",ROUND((B35-C35)*10000/1,0)&" bb") |
| EBIT / P&L interest expense | =[2]Zaduženost!$C$5 | =[2]Zaduženost!$B$5 | =+B36/C36-1 |
| Net debt / EBITDA | =[2]Zaduženost!$C$4 | =[2]Zaduženost!$B$4 | =+B37/C37-1 |
| Sales (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | ='[3]Grupa konsol '!$W$9/1000 | ='[3]Grupa konsol '!$K$9/1000 | =+B2/C2-1 |
| Sales revenues of Podravka Group | ='[3]Grupa konsol '!$W$14/1000 | ='[3]Grupa konsol '!$K$14/1000 | =+B3/C3-1 |
| Sales revenues of Food | ='[4]Profitabilnost 1Q 2020.'!$C$22 | ='[4]Profitabilnost 1Q 2020.'!$B$22 | =+B4/C4-1 |
| Sales revenues of Pharma | ='[4]Profitabilnost 1Q 2020.'!$C$40 | ='[4]Profitabilnost 1Q 2020.'!$B$40 | =+B5/C5-1 |
| Podravka Group's profitability (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Group's gross profit | ='[4]Profitabilnost 1Q 2020.'!$C$4 | ='[4]Profitabilnost 1Q 2020.'!$B$4 | =+B7/C7-1 |
| Group's gross profit margin | ='[4]Profitabilnost 1Q 2020.'!$C$9 | ='[4]Profitabilnost 1Q 2020.'!$B$9 | =+IF((ROUND((B8-C8)*10000/1,0))>0,"+"&ROUND((B8-C8)*10000/1,0)&" bb",ROUND((B8-C8)*10000/1,0)&" bb") |
| Group's EBITDA | ='[4]Profitabilnost 1Q 2020.'!$C$5 | ='[4]Profitabilnost 1Q 2020.'!$B$5 | =+B9/C9-1 |
| Group's EBITDA margin | ='[4]Profitabilnost 1Q 2020.'!$C$10 | ='[4]Profitabilnost 1Q 2020.'!$B$10 | =+IF((ROUND((B10-C10)*10000/1,0))>0,"+"&ROUND((B10-C10)*10000/1,0)&" bb",ROUND((B10-C10)*10000/1,0)&" bb") |
| Group's EBIT | ='[4]Profitabilnost 1Q 2020.'!$C$6 | ='[4]Profitabilnost 1Q 2020.'!$B$6 | =+B11/C11-1 |
| Group's EBIT margin | ='[4]Profitabilnost 1Q 2020.'!$C$11 | ='[4]Profitabilnost 1Q 2020.'!$B$11 | =+IF((ROUND((B12-C12)*10000/1,0))>0,"+"&ROUND((B12-C12)*10000/1,0)&" bb",ROUND((B12-C12)*10000/1,0)&" bb") |
| Group's net profit after MI | ='[4]Profitabilnost 1Q 2020.'!$C$7 | ='[4]Profitabilnost 1Q 2020.'!$B$7 | =+B13/C13-1 |
| Group's net profit margin after MI | ='[4]Profitabilnost 1Q 2020.'!$C$12 | ='[4]Profitabilnost 1Q 2020.'!$B$12 | =+IF((ROUND((B14-C14)*10000/1,0))>0,"+"&ROUND((B14-C14)*10000/1,0)&" bb",ROUND((B14-C14)*10000/1,0)&" bb") |
| Podravka Group's balance sheet (in HRKm) | 31.3.2020 | 31.12.2019 | % change |
| Total assets | =[4]BS!$E$27/1000 | =[4]BS!$C$27/1000 | =+B16/C16-1 |
| Shareholders' equity | =[4]BS!$E$37/1000 | =[4]BS!$C$37/1000 | =+B17/C17-1 |
| Minority interests | =[4]BS!$E$38/1000 | =[4]BS!$C$38/1000 | =+B18/C18-1 |
| Cash and cash equivalents | =[4]BS!$E$23/1000 | =[4]BS!$C$23/1000 | =+B19/C19-1 |
| Financial debt | =[4]Zaduženost!$C$22 | =[4]Zaduženost!$B$22 | =+B20/C20-1 |
| Net debt | =[4]Zaduženost!$C$21 | =[4]Zaduženost!$B$21 | =+B21/C21-1 |
| Podravka Group's cash flow (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Net cash flow from operating activities | =[4]CF!$D$50/1000 | =[4]CF!$C$50/1000 | =+B23/C23-1 |
| Capital expenditures | =-[4]CF!$D$58/1000 | =-[4]CF!$C$58/1000 | =+B24/C24-1 |
| Depreciation and amortization | =[4]CF!$D$9/1000 | =[4]CF!$C$9/1000 | =+B25/C25-1 |
| Free cash flow | =B23-B24 | =C23-C24 | =+B26/C26-1 |
| Podravka Group's ratios and indicators | 31.3.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,756 | 6,652 | =+B28/C28-1 |
| P&L interest expense (in HRKm) | =[4]Zaduženost!$C$3 | =[4]Zaduženost!$B$3 | =+B29/C29-1 |
| Sales revenues / Number of employees (in HRK000) | =[4]Dionica!$AI$21*1000/B28 | =[4]Dionica!$AI$24*1000/C28 | =+B30/C30-1 |
| Net profit after MI / Sales revenues (in HRK000) | =[4]Dionica!$AI$36*1000/B28 | =[4]Dionica!$AI$39*1000/C28 | =+B31/C31-1 |
| Return on average assets | =(('[4]P&L'!$E$29-'[4]P&L'!$C$29+'[5]P&L'!$E$29)/1000)/((AVERAGE(B16:C16))) | ='[6]1.-12. 2019.'!$B$32 | =+IF((ROUND((B32-C32)*10000/1,0))>0,"+"&ROUND((B32-C32)*10000/1,0)&" bb",ROUND((B32-C32)*10000/1,0)&" bb") |
| Return on average capital | =(('[4]P&L'!$E$29-'[4]P&L'!$C$29+'[5]P&L'!$E$29)/1000)/((AVERAGE(B17:C17)+AVERAGE(B18:C18))) | ='[6]1.-12. 2019.'!$B$33 | =+IF((ROUND((B33-C33)*10000/1,0))>0,"+"&ROUND((B33-C33)*10000/1,0)&" bb",ROUND((B33-C33)*10000/1,0)&" bb") |
| Return on average invested capital | =((B11+'[6]1.-12.2018.'!B11-C11)*(1-0.18))/((AVERAGE(B17:C17)+AVERAGE(B20:C20)+AVERAGE(B18:C18)-AVERAGE(B19:C19))) | ='[6]1.-12. 2019.'!$B$34 | =+IF((ROUND((B34-C34)*10000/1,0))>0,"+"&ROUND((B34-C34)*10000/1,0)&" bb",ROUND((B34-C34)*10000/1,0)&" bb") |
| Total shareholders' equity / Total assets | =(B17+B18)/B16 | =(C17+C18)/C16 | =+IF((ROUND((B35-C35)*10000/1,0))>0,"+"&ROUND((B35-C35)*10000/1,0)&" bb",ROUND((B35-C35)*10000/1,0)&" bb") |
| EBIT / P&L interest expense | =[4]Zaduženost!$C$5 | =[4]Zaduženost!$B$5 | =+B36/C36-1 |
| Net debt / EBITDA | =[4]Zaduženost!$C$4 | =[4]Zaduženost!$B$4 | =+B37/C37-1 |
| Sales (in HRKm) | 2019 | 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | ='[7]1.-12. 2019.'!$B$2 | ='[7]1.-12. 2019.'!C2 | ='[7]1.-12. 2019.'!D2 |
| Sales revenues of Podravka Group | ='[7]1.-12. 2019.'!B3 | ='[7]1.-12. 2019.'!C3 | ='[7]1.-12. 2019.'!D3 |
| Sales revenues of Food | ='[7]1.-12. 2019.'!B4 | ='[7]1.-12. 2019.'!C4 | ='[7]1.-12. 2019.'!D4 |
| Sales revenues of Pharma | ='[7]1.-12. 2019.'!B5 | ='[7]1.-12. 2019.'!C5 | ='[7]1.-12. 2019.'!D5 |
| Podravka Group's profitability (in HRKm) | 2019 | 2018 | % change |
| Group's gross profit | ='[7]1.-12. 2019.'!B7 | ='[7]1.-12. 2019.'!C7 | ='[7]1.-12. 2019.'!D7 |
| Group's gross profit margin | ='[7]1.-12. 2019.'!$B$8 | ='[7]1.-12. 2019.'!C8 | ='[7]1.-12. 2019.'!D8 |
| Group's EBITDA | ='[7]1.-12. 2019.'!B9 | ='[7]1.-12. 2019.'!C9 | ='[7]1.-12. 2019.'!D9 |
| Group's EBITDA margin | ='[7]1.-12. 2019.'!B10 | ='[7]1.-12. 2019.'!C10 | ='[7]1.-12. 2019.'!D10 |
| Group's EBIT | ='[7]1.-12. 2019.'!B11 | ='[7]1.-12. 2019.'!C11 | ='[7]1.-12. 2019.'!D11 |
| Group's EBIT margin | ='[7]1.-12. 2019.'!B12 | ='[7]1.-12. 2019.'!C12 | ='[7]1.-12. 2019.'!D12 |
| Group's net profit after MI | ='[7]1.-12. 2019.'!B13 | ='[7]1.-12. 2019.'!C13 | ='[7]1.-12. 2019.'!D13 |
| Group's net profit margin after MI | ='[7]1.-12. 2019.'!B14 | ='[7]1.-12. 2019.'!C14 | ='[7]1.-12. 2019.'!D14 |
| Podravka Group's balance sheet (in HRKm) | 2019 | 2018 | % change |
| Total assets | ='[7]1.-12. 2019.'!B16 | 4,846.1 | ='[7]1.-12. 2019.'!D16 |
| Shareholders' equity | ='[7]1.-12. 2019.'!B17 | 3,005.3 | ='[7]1.-12. 2019.'!D17 |
| Minority interests | ='[7]1.-12. 2019.'!B18 | 42.4 | ='[7]1.-12. 2019.'!D18 |
| Cash and cash equivalents | ='[7]1.-12. 2019.'!B19 | 211.1 | ='[7]1.-12. 2019.'!D19 |
| Financial debt | ='[7]1.-12. 2019.'!B20 | 966.2 | ='[7]1.-12. 2019.'!D20 |
| Net debt | ='[7]1.-12. 2019.'!B21 | 755.1 | ='[7]1.-12. 2019.'!D21 |
| Podravka Group's cash flow (in HRKm) | 31.12.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | ='[7]1.-12. 2019.'!B23 | ='[7]1.-12. 2019.'!C23 | ='[7]1.-12. 2019.'!D23 |
| Capital expenditures | ='[7]1.-12. 2019.'!B24 | ='[7]1.-12. 2019.'!C24 | ='[7]1.-12. 2019.'!D24 |
| Depreciation and amortization | ='[7]1.-12. 2019.'!B25 | ='[7]1.-12. 2019.'!C25 | ='[7]1.-12. 2019.'!D25 |
| Free cash flow | ='[7]1.-12. 2019.'!B26 | ='[7]1.-12. 2019.'!C26 | ='[7]1.-12. 2019.'!D26 |
| Podravka Group's ratios and indicators | 31.12.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | ='[7]1.-12. 2019.'!B28 | ='[7]1.-12. 2019.'!C28 | ='[7]1.-12. 2019.'!D28 |
| P&L interest expense (in HRKm) | ='[7]1.-12. 2019.'!B29 | ='[7]1.-12. 2019.'!C29 | ='[7]1.-12. 2019.'!D29 |
| Sales revenues / Number of employees (in HRK000) | ='[7]1.-12. 2019.'!B30 | ='[7]1.-12. 2019.'!C30 | ='[7]1.-12. 2019.'!D30 |
| Net profit after MI / Sales revenues (in HRK000) | ='[7]1.-12. 2019.'!B31 | ='[7]1.-12. 2019.'!C31 | ='[7]1.-12. 2019.'!D31 |
| Return on average assets | ='[7]1.-12. 2019.'!B32 | ='[7]1.-12. 2019.'!C32 | ='[7]1.-12. 2019.'!D32 |
| Return on average capital | ='[7]1.-12. 2019.'!B33 | ='[7]1.-12. 2019.'!C33 | ='[7]1.-12. 2019.'!D33 |
| Return on average invested capital | ='[7]1.-12. 2019.'!B34 | ='[7]1.-12. 2019.'!C34 | ='[7]1.-12. 2019.'!D34 |
| Total shareholders' equity / Total assets | ='[7]1.-12. 2019.'!B35 | ='[7]1.-12. 2019.'!C35 | ='[7]1.-12. 2019.'!D35 |
| EBIT / P&L interest expense | ='[7]1.-12. 2019.'!B36 | ='[7]1.-12. 2019.'!C36 | ='[7]1.-12. 2019.'!D36 |
| Net debt / EBITDA | ='[7]1.-12. 2019.'!B37 | ='[7]1.-12. 2019.'!C37 | ='[7]1.-12. 2019.'!D37 |
| Sales (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,261.3 | 3,088.1 | 5.6% |
| Sales revenues of Podravka Group | 3,238.5 | 3,078.3 | 5.2% |
| Sales revenues of Food | 2,550.3 | 2,439.0 | 4.6% |
| Sales revenues of Pharma | 688.2 | 639.3 | 7.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
| Group's gross profit | 1,206.1 | 1,144.2 | 5.4% |
| Group's gross profit margin | 37.2% | 37.2% | +7 bb |
| Group's EBITDA | 413.2 | 379.4 | 8.9% |
| Group's EBITDA margin | 12.8% | 12.3% | +43 bb |
| Group's EBIT | 252.2 | 238.8 | 5.6% |
| Group's EBIT margin | 7.8% | 7.8% | +3 bb |
| Group's net profit after MI | 194.3 | 185.9 | 4.5% |
| Group's net profit margin after MI | 6.0% | 6.0% | -4 bb |
| Podravka Group's balance sheet (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
| Total assets | 4,985.4 | 4,846.1 | 2.9% |
| Shareholders' equity | 3,137.2 | 3,005.3 | 4.4% |
| Minority interests | 45.6 | 42.4 | 7.6% |
| Cash and cash equivalents | 129.3 | 211.1 | -38.7% |
| Financial debt | 984.6 | 966.2 | 1.9% |
| Net debt | 855.2 | 755.1 | 13.3% |
| Podravka Group's cash flow (in HRKm) | 30.09.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | 219.4 | 146.6 | 49.7% |
| Capital expenditures | 101.4 | 108.5 | -6.5% |
| Depreciation and amortization | 161.1 | 140.6 | 14.5% |
| Free cash flow | 118.0 | 38.1 | 209.7% |
| Podravka Group's ratios and indicators | 30.09.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,872 | 6,517 | 5.4% |
| P&L interest expense (in HRKm) | 15.5 | 17.9 | -13.8% |
| Sales revenues / Number of employees (in HRK000) | 639.2 | 649.4 | -1.6% |
| Net profit after MI / Sales revenues (in HRK000) | 31.1 | 31.6 | -1.3% |
| Return on average assets | 4.5% | 4.3% | +19 bb |
| Return on average capital | 7.0% | 7.1% | -8 bb |
| Return on average invested capital | 5.7% | 5.4% | +25 bb |
| Total shareholders' equity / Total assets | 63.8% | 62.9% | +95 bb |
| EBIT / P&L interest expense | 17.6 | 14.4 | 22.0% |
| Net debt / EBITDA | 1.7 | 1.6 | 5.6% |
| Sales (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,156.2 | 2,031.7 | 6.1% |
| Sales revenues of Podravka Group | 2,139.5 | 2,035.1 | 5.1% |
| Sales revenues of Food | 1,684.3 | 1,602.2 | 5.1% |
| Sales revenues of Pharma | 455.2 | 432.8 | 5.2% |
| Podravka Group's profitability (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
| Group's gross profit | 803.8 | 760.6 | 5.7% |
| Group's gross profit margin | 37.6% | 37.4% | +19 bp |
| Group's EBITDA | 288.6 | 243.5 | 18.5% |
| Group's EBITDA margin | 13.5% | 12.0% | +152 bp |
| Group's EBIT | 182.9 | 149.2 | 22.6% |
| Group's EBIT margin | 8.5% | 7.3% | +122 bp |
| Group's net profit after MI | 140.0 | 120.7 | 16.1% |
| Group's net profit margin after MI | 6.5% | 5.9% | +62 bp |
| Podravka Group's balance sheet (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
| Total assets | 4,939.8 | 4,846.1 | 1.9% |
| Shareholders' equity | 3,080.8 | 3,005.3 | 2.5% |
| Minority interests | 44.6 | 42.4 | 5.3% |
| Cash and cash equivalents | 146.9 | 211.1 | -30.4% |
| Financial debt | 922.8 | 966.2 | -4.5% |
| Net debt | 775.9 | 755.1 | 2.7% |
| Podravka Group's cash flow (in HRKm) | 30.06.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | 152.8 | 99.0 | 53.8% |
| Capital expenditures | 65.6 | 67.4 | -2.7% |
| Depreciation and amortization | 105.8 | 94.3 | 12.1% |
| Free cash flow | 87.2 | 31.6 | 175.8% |
| Podravka Group's ratios and indicators | 30.06.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,793 | 6,517 | 4.2% |
| P&L interest expense (in HRKm) | 16.5 | 17.9 | -8.2% |
| Sales revenues / Number of employees (in HRK000) | 638.4 | 649.4 | -1.7% |
| Net profit after MI / Sales revenues (in HRK000) | 33.1 | 31.6 | 4.9% |
| Return on average assets | 5.0% | 4.5% | +52 bp |
| Return on average capital | 7.9% | 7.5% | +46 bp |
| Return on average invested capital | 6.2% | 5.4% | +37 bp |
| Total shareholders' equity / Total assets | 63.3% | 62.9% | +38 bp |
| EBIT / P&L interest expense | 18.7 | 15.2 | 23.5% |
| Net debt / EBITDA | 1.5 | 1.6 | -6.8% |
| Sales (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,030.6 | 987.1 | 4.4% |
| Sales revenues of Podravka Group | 1,017.4 | 988.9 | 2.9% |
| Sales revenues of Food | 815.5 | 789.8 | 3.3% |
| Sales revenues of Pharma | 201.9 | 199.0 | 1.4% |
| Podravka Group's profitability (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
| Group's gross profit | 384.0 | 371.5 | 3.4% |
| Group's gross profit margin | 37.7% | 37.6% | +17 bb |
| Group's EBITDA | 156.5 | 135.6 | 15.4% |
| Group's EBITDA margin | 15.4% | 13.7% | +166 bp |
| Group's EBIT | 104.4 | 87.7 | 19.1% |
| Group's EBIT margin | 10.3% | 8.9% | +139 bp |
| Group's net profit after MI | 80.1 | 69.8 | 14.8% |
| Group's net profit margin after MI | 7.9% | 7.1% | +82 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2019 | 31.12.2018 | % change |
| Total assets | 4,904.6 | 4,846.1 | 1.2% |
| Shareholders' equity | 3,086.5 | 3,005.3 | 2.7% |
| Minority interests | 43.9 | 42.4 | 3.5% |
| Cash and cash equivalents | 145.1 | 211.1 | -31.3% |
| Financial debt | 984.2 | 966.2 | 1.9% |
| Net debt | 839.1 | 755.1 | 11.1% |
| Podravka Group's cash flow (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
| Net cash flow from operating activities | 50.3 | -41.4 | -221.3% |
| Capital expenditures | 24.1 | 24.5 | -1.5% |
| Depreciation and amortization | 52.1 | 47.9 | 8.6% |
| Free cash flow | 26.2 | (65.9) | -139.7% |
| Podravka Group's ratios and indicators | 31.03.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,657 | 6,517 | 2.1% |
| P&L interest expense (in HRKm) | 17.1 | 17.9 | -4.6% |
| Sales revenues / Number of employees (in HRK000) | 640.0 | 649.4 | -1.4% |
| Net profit after MI / Sales revenues (in HRK000) | 32.5 | 31.6 | 2.8% |
| Return on average assets | 4.6% | 4.3% | +29 bp |
| Return on average capital | 7.2% | 7.1% | +8 bp |
| Return on average invested capital | 5.8% | 5.4% | +37 bp |
| Total shareholders' equity / Total assets | 63.8% | 62.9% | +93 bp |
| EBIT / P&L interest expense | 16.1 | 14.4 | 11.6% |
| Net debt / EBITDA | 1.7 | 1.6 | 6.3% |
| Sales (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,240.5 | 4,110.9 | 3.2% |
| Sales revenues of Podravka Group | 4,232.1 | 4,111.2 | 2.9% |
| Sales revenues of Food | 3,335.3 | 3,243.7 | 2.8% |
| Sales revenues of Pharma | 896.9 | 867.5 | 3.4% |
| Podravka Group's profitability (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
| Group's gross profit | 1,558.4 | 1,484.1 | 5.0% |
| Group's gross profit margin | 36.8% | 36.1% | +72 bp |
| Group's EBITDA | 463.7 | 374.1 | 24.0% |
| Group's EBITDA margin | 11.0% | 9.1% | +186 bp |
| Group's EBIT | 258.4 | 91.1 | 183.8% |
| Group's EBIT margin | 6.1% | 2.2% | +389 bp |
| Group's net profit after MI | 205.7 | 18.2 | 1027.2% |
| Group's net profit margin after MI | 4.9% | 0.4% | +442 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2018 | 31.12.2017 | % change |
| Total assets | 4,846.1 | 5,061.4 | (0.0%) |
| Shareholders' equity | 3,005.3 | 2,860.1 | 5.1% |
| Minority interests | 42.4 | 36.7 | 15.5% |
| Cash and cash equivalents | 211.1 | 362.1 | (0.4%) |
| Financial debt | 966.2 | 1,271.1 | (0.2%) |
| Net debt | 755.1 | 909.1 | (0.2%) |
| Podravka Group's cash flow (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
| Net cash flow from operating activities | 316.9 | 473.4 | (0.3%) |
| Capital expenditures | 166.1 | 206.8 | (0.2%) |
| Depreciation and amortization | 192.7 | 194.0 | (0.0%) |
| Free cash flow | 150.8 | 266.6 | (0.4%) |
| Podravka Group's ratios and indicators | 31.12.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,517 | 6,306 | 3.3% |
| P&L interest expense (in HRKm) | 17.9 | 26.9 | (0.3%) |
| Sales revenues / Number of employees (in HRK000) | 649.4 | 651.9 | (0.0%) |
| Net profit after MI / Sales revenues (in HRK000) | 31.6 | 2.9 | 990.7% |
| Return on average assets | 4.3% | 0.5% | +381 bp |
| Return on average capital | 7.1% | 0.8% | +630 bp |
| Return on average invested capital | 5.4% | 1.9% | +351 bp |
| Total shareholders' equity / Total assets | 62.9% | 57.2% | +566 bp |
| EBIT / P&L interest expense | 14.4 | 3.4 | 325.3% |
| Net debt / EBITDA | 1.6 | 2.4 | (0.3%) |
| Sales (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,088.1 | 2,979.5 | 3.6% |
| Sales revenues of Podravka Group | 3,078.3 | 2,983.1 | 3.2% |
| Sales revenues of Food | 2,439.0 | 2,372.3 | 2.8% |
| Sales revenues of Pharma | 639.3 | 610.8 | 4.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Group's gross profit | 1,144.2 | 1,061.7 | 7.8% |
| Group's gross profit margin | 37.2% | 35.6% | +158 bp |
| Group's EBITDA | 379.4 | 254.4 | 49.1% |
| Group's EBITDA margin | 12.3% | 8.5% | +380 bp |
| Group's EBIT | 238.8 | 110.5 | 116.0% |
| Group's EBIT margin | 7.8% | 3.7% | +405 bp |
| Group's net profit after MI | 185.9 | 54.1 | 243.8% |
| Group's net profit margin after MI | 6.0% | 1.8% | +423 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2018 | 31.12.2017 | % change |
| Total assets | 4,848.1 | 5,061.4 | (0.0%) |
| Shareholders' equity | 2,987.1 | 2,860.1 | 4.4% |
| Minority interests | 40.5 | 36.7 | 10.5% |
| Cash and cash equivalents | 146.0 | 362.1 | (0.6%) |
| Financial debt | 1,015.1 | 1,271.1 | (0.2%) |
| Net debt | 869.1 | 909.1 | (0.0%) |
| Podravka Group's cash flow (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Net cash flow from operating activities | 146.6 | 193.1 | (0.2%) |
| Capital expenditures | 108.5 | 158.8 | (0.3%) |
| Depreciation and amortization | 140.6 | 143.8 | (0.0%) |
| Free cash flow | 38.1 | 34.3 | 11.0% |
| Podravka Group's ratios and indicators | 30.09.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,626 | 6,306 | 5.1% |
| P&L interest expense (in HRKm) | 20.5 | 26.9 | (0.2%) |
| Sales revenues / Number of employees (in HRK000) | 634.8 | 651.9 | (0.0%) |
| Net profit after MI / Sales revenues (in HRK000) | 22.7 | 2.9 | 682.8% |
| Return on average assets | 3.1% | 0.5% | +266 bp |
| Return on average capital | 5.2% | 0.8% | +439 bp |
| Return on average invested capital | 4.7% | 1.9% | +275 bp |
| Total shareholders' equity / Total assets | 62.5% | 57.2% | +522 bp |
| EBIT / P&L interest expense | 10.7 | 3.4 | 216.1% |
| Net debt / EBITDA | 1.7 | 2.4 | (0.3%) |
| Sales (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,031.7 | 1,944.0 | 4.5% |
| Sales revenues of Podravka Group | 2,035.1 | 1,951.2 | 4.3% |
| Sales revenues of Food | 1,602.2 | 1,544.4 | 3.7% |
| Sales revenues of Pharma | 432.8 | 406.8 | 6.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
| Group's gross profit | 760.6 | 693.7 | 9.7% |
| Group's gross profit margin | 37.4% | 35.6% | +182 bp |
| Group's EBITDA | 243.5 | 140.0 | 74.0% |
| Group's EBITDA margin | 12.0% | 7.2% | +479 bp |
| Group's EBIT | 149.2 | 44.8 | 233.2% |
| Group's EBIT margin | 7.3% | 2.3% | +504 bp |
| Group's net profit after MI | 120.7 | 24.8 | 386.7% |
| Group's net profit margin after MI | 5.9% | 1.3% | +466 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2018 | 31.12.2017 | % change |
| Total assets | 4,852.9 | 5,061.4 | -4.1% |
| Shareholders' equity | 2,915.9 | 2,860.1 | 2.0% |
| Minority interests | 38.1 |